Ovarian Cancer
Our major research goal is to identify new ways to diagnose women with early stage curable ovarian cancer. To this end, we use a combination of genetic and epigenetic approaches to understand the molecular changes involved in the development of ovarian cancer. Together with the Epigenetics Group, our current primary focus is the identification of a panel of methylated genes that may have potential as diagnostic markers for early stage ovarian cancer. These markers will likely include genes that control the development of ovarian cancer, and therefore may also include potential novel therapeutic targets for treatment of advanced disease.
Staff
 Senior Research OfficerDr Kristina Warton |
|
 Research AssistantMaria Gonzalez |
 PhD StudentBrian Gloss |
 Clinical Data CoordinatorTina Barber |
|
| Honorary Researcher Rajmohan Murali |
Data Entry Clerk Paige Barber |
News
Nuns on the Run from Dubbo to Darlinghurst for Cancer
MEDIA RELEASE:
19 Apr 2009
Led by two Sisters of Charity, The Nuns’ Run will cover the 400 km distance from Dubbo to Darlinghurst in an effort to raise cancer awareness and crucial funds for the establishment of a new $100 million Cancer Centre within the St Vincent’s Research Precinct, Sydney. Embarking on their journey on 24 May, Sisters Helen Clarke and Leone Wittmack are hoping to arrive in Sydney on 5 June.
Garvan and St Vincent’s to Build $100 million Australian Cancer Centre
MEDIA RELEASE:
22 Oct 2008
The Garvan Institute of Medical Research and St Vincents & Mater Health Sydney will today announce plans to jointly establish a new $100 million Cancer Centre within the St Vincent’s Research Precinct. The Garvan St Vincent’s Campus Cancer Centre (GSVCCC) will integrate internationally acclaimed cancer research with best practice cancer services, enabling research findings to move quickly into patient care.
